A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT07681596 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07681596
- Sponsor
- AstraZeneca
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-09
- Primary completion
- 2029-10-30
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.